Chest Medicine

“CONCLUSIONS: People <65 years old have very small risks of COVID-19 death even in the hotbeds of the pandemic and deaths for people <65 years without underlying predisposing conditions are remarkably uncommon. Strategies focusing specifically on protecting high-risk elderly individuals should be considered in managing the pandemic.”

Related perspectives from the same author:

Video: Perspectives on the Pandemic with Dr. John Ioannidis

Podcast: Be it resolved, we are making high-stakes decisions about the COVID-19 pandemic without reliable data. – Munk Debates Podcast

Editorial: Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation

Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT

AHA Guidance: Caution Recommended on COVID-19 Treatment with Hydroxychloroquine and Azithromycin for Patients with Cardiovascular Disease

9 Apr, 2020 | 03:45h | UTC

Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment – Circulation

News Release: Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – American Heart Association

Commentaries: Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD – Cardiovascular Business AND AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients – DAIC

Safety Considerations with Chloroquine, Hydroxychloroquine and Azithromycin in the Management of SARS-CoV-2 Infection

9 Apr, 2020 | 03:42h | UTC

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection – Canadian Medical Association Journal

Commentary: Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19 – Canadian Medical Association Journal

Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort

9 Apr, 2020 | 03:34h | UTC

[Preprint] Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications – medRxiv

Commentaries: expert reaction to preprint (not a published paper) on antibody responses to the COVID-19 virus (SARS-CoV-2) in a group of recovered people in Shanghai – Science Media Centre AND Covid-19 Antibody Update for April 8 – Science Translational Medicine AND Coronavirus: low antibody levels raise questions about reinfection risk – South China Morning Post

Editorials: Covid-19 Testing Times

9 Apr, 2020 | 03:26h | UTC

Covid-19: testing times – The BMJ

PCR Assays May Turn Positive After Discharge

9 Apr, 2020 | 03:29h | UTC

PCR Assays Turned Positive in 25 Discharged COVID-19 Patients – Clinical Infectious Diseases

Related Commentary on Twitter

https://twitter.com/GermHunterMD/status/1247937913175695363

Disruptive Opinion on the Use of Ventilators in COVID-19

9 Apr, 2020 | 03:22h | UTC

With ventilators running out, doctors say the machines are overused for Covid-19 – STAT

Commentary: Expert reaction to new WHO advice on use of facemasks in the context of COVID-19 – Science Media Centre

Review: Intensive Care Management of COVID-19

8 Apr, 2020 | 01:36h | UTC

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations – The Lancet Respiratory Medicine

Commentary: Understanding pathways to death in patients with COVID-19 – The Lancet Respiratory Medicine

Video: COVID-19 Clinical Update

8 Apr, 2020 | 01:35h | UTC

COVID-19 Clinical Update – JAMA

COVID‐19: ATS Interim Guidance on Management Pending Empirical Evidence

7 Apr, 2020 | 04:39h | UTC

COVID‐19: Interim Guidance on Management Pending Empirical Evidence. From an American Thoracic Society‐led International Task Force

Commentary: ATS publishes new guidance on COVID-19 management – American Thoracic Society

Study: Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2

7 Apr, 2020 | 04:24h | UTC

Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients – Annals of Internal Medicine

Commentary: Neither surgical nor cotton masks effectively filter SARS COV-2 – American College of Physicians

Editorial: Is CPR Justified for Hospital Patients with Covid-19?

7 Apr, 2020 | 04:26h | UTC

Editorial: Cardiopulmonary Resuscitation after Hospital Admission with Covid-19 – The BMJ

“This pandemic has changed the risk-benefit balance for CPR: from “there is no harm in trying” to “there is little benefit to the patient, and potentially significant harm to staff.””

Meta-Analysis: Medical Masks vs. N95 Respirators for Preventing COVID‐19 in Health Care Workers

7 Apr, 2020 | 04:22h | UTC

Medical Masks vs N95 Respirators for Preventing COVID‐19 in Health Care Workers: A Systematic Review and Meta‐Analysis of Randomized Trials – Influenza

Commentary: Surgical masks likely good for most COVID-19 treatment – McMaster University

Olfactory Loss Function as a Possible Symptom of COVID-19

Podcast: Reusing Face Masks and N95 Respirators

COVID‐19 And Older Adults: What We Know

Review: Should Chloroquine and Hydroxychloroquine be Used to Treat COVID-19?

Study: The COVID-19 Coronavirus Disease May Be Twice As Contagious As We Thought

Systematic Review: How Effective is Quarantine to Control Coronavirus (COVID-19)?

Video: Coronavirus Q&A with Anthony Fauci, MD

Podcast: Emerging Tools in the Fight Against Covid-19

Editorial: Chloroquine and Hydroxychloroquine in Covid-19

Study: Population-level COVID-19 Mortality Risk